Thc Farmaceuticals, IncOTC: CBDG

CBDUAL BIOTECHNOLOGY CORP announces open house to celebrate launch of our new clinical research trials center

· Issued by THC Farmaceuticals, Inc

For Immediate Release

April 15 2019

CBDual Biotechnology Corp announced today that in partnership with 1000 Smiles Dental which is located in Newbury Park, CA that its grand opening ceremony will be held on Tuesday April 16th at 4 pm PST.  The ribbon cutting will be held with the leadership and members of the Thousand Oaks Chamber of Commerce.

Our state-of- the-art clinical trials facility is an efficiently designed suite featuring attractive finishes, plenty of outside light and modern technology. It is located in the Regency Medical plaza, a well-known and established medical office complex in Ventura County, featuring an on-site compounding pharmacy and located in close proximity to Los Robles Regional Medical Center.

CBDual Biotechnology Corp partnered up with 1000 Smiles Dental to create the first CBD based dental hygiene product line and conduct clinical trials in the first research center of its kind.  The clinical trials will begin its pre-clinical phase within the next few months.

“Cbdual’s new clinical trial facility holds the promise to discover new ways cannabidiol  (CBD) can be implemented in medical and dental treatments and serve to be an alternative treatment  option for oral health and wellbeing,” Dr. Greg Rubin stated, our Founder and CEO. “As clinical research into the therapeutic value of cannabinoids has proliferated recently, researchers understanding of cannabis many natural compounds remarkable capacity to improve and treat diseases and conditions , including potentially gum disease, has increased.

With the emerging indications and abundance of clinical research indicating the effectiveness of CBD (cannabidiol) in medicine, such as the antibacterial and anti-inflammatory and several other features being the most well-known properties, these happen to be the most needed qualities in dentistry. Clinical trials will be conducted on volunteers. Early registration to participate in clinical trials will begin soon.

 ” We’re aware of the growing public interest in cannabis and cannabis-derived products, including cannabidiol (CBD).”  said FDA  Commissioner Scott Gottlieb, M.D.  in his recent statement.

CBDual Biotechnology will apply for FDA approval for its product line upon completion of a series of clinical trials.

The Surgeon General’s Report on health was published few years ago. A major theme of this report is that oral health means much more than healthy teeth. Consequently, a second theme of the report is that oral health is integral to general health. “You cannot be healthy without oral health” stated Dr. Rubin

One out of every two American adults aged 30 and over has periodontal disease, according to recent findings from the Centers for Disease Control and Prevention (CDC). A study entitled “Prevalence of Periodontitis in Adults in the United States: 2009 and 2010” estimates that 47.2 percent, or 64.7 million American adults, have mild, moderate or severe periodontitis, the more advanced form of periodontal disease. In adults 65 and older, prevalence rates increase to 70.1 percent. This study is published in the Journal of Dental Research, the official publication of the International and American Associations for Dental Research. CBDual Biotechnology Corp is well positioned to pioneer the development and commercialization of CBD Based oral health products.

Volunteers who wish to be part of the first ever dental clinical trials for CBD may fill out an application on the company website to see if they qualify.

For more information, please email us at info@1000smiles.la or info@Cbdual.com or visit 1000smiles.la or CBDUAL.com

About CBDual Biotechnology Corp.

CBDual Biotechnology Corp is a subsidiary of THC Farmaceuticals, Inc (OTC:CBDG), a publicly traded company, which is a Biotechnology company with propriety technology for enhanced oral delivery of bioactive cannabinoids and other delivery methods. This technology promotes overall oral health due to higher effectiveness of the delivery methodology. The company was founded in 2016 and is headquartered in California, with its R&D in the US and Israel. For More information about CBDual, please visit our website: www.CBDual.com

About 1000 Smiles Dental

1000 Smiles was founded with one goal in mind: to provide cutting-edge care and proven dental treatment to its patients in Thousand Oaks and the neighboring San Fernando and Conejo Valleys. Founded by Dr. Greg Rubin, DDS, who has more than thirty five years of clinical experience practicing on two continents, our dental center is a model, state-of-the-art, dental practice that offers a wide range of dental services, including examinations, cosmetic dentistry, dental implants and much more.

Forward-Looking Statements:

This press release contains "forward-looking statements." Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.

Source: Investor relations CBDG

For more information: info@cbdg.com

Company analysis

Earlier from Thc Farmaceuticals

All Thc Farmaceuticals news releases